首页> 外文期刊>BMC Musculoskeletal Disorders >Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study
【24h】

Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study

机译:炎性风湿病患者改变疾病抗风湿药的障碍和促进剂:基于定性理论的研究

获取原文
       

摘要

Background Although disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of treatment for inflammatory rheumatic diseases, medication adherence to DMARDs is often suboptimal. Effective interventions to improve adherence to DMARDs are lacking, and new targets are needed to improve adherence. The aim of the present study was to explore patients’ barriers and facilitators of optimal DMARD use. These factors might be used as targets for adherence interventions. Methods In a mixed method study design, patients ( n =?120) with inflammatory arthritis (IA) completed a questionnaire based on an existing adapted Theoretical Domains Framework (TDF) to identify facilitators and barriers of DMARD use. A subgroup of these patients ( n =?21) participated in focus groups to provide insights into their facilitators and barriers. The answers to the questionnaires and responses of the focus groups were thematically coded by three researchers independently and subsequently categorized. Results The barriers and facilitators that were reported by IA patients presented large inter-individual variations. The identified barriers and facilitators could be captured in the following domains based on an adapted TDF: ( i ) knowledge, ( ii ) emotions, ( iii ) attention, memory, and decision processes, ( iv ) social influences, ( v ) beliefs about capability, ( vi ) beliefs about consequences, ( vii ) motivation and goals, ( viii ) goal conflict, ( ix ) environmental context and resources, and ( x ) skills. Conclusions Patients with IA have a variety of barriers and facilitators with regard to their DMARD use. All of these barriers and facilitators could be categorized into adapted domains of the TDF. Interventions that address individual facilitators and barriers, based on capability, opportunity, and motivation, are needed to develop strategies for medication adherence that are tailored to individual patient needs.
机译:背景技术尽管改变病情的抗风湿药(DMARD)是治疗炎症性风湿病的基石,但对DMARDs的药物依从性通常欠佳。缺乏改善对DMARD依从性的有效干预措施,并且需要新的目标来提高依从性。本研究的目的是探讨患者最佳DMARD使用的障碍和促进因素。这些因素可以用作坚持干预的目标。方法在一项混合方法研究设计中,炎性关节炎(IA)患者(n = 120)填写了一份基于现有适应性理论领域框架(TDF)的调查表,以识别促进DMARD使用的障碍。这些患者的一个亚组(n = 21)参加了焦点小组,以深入了解其促进因素和障碍。问卷的答案和焦点小组的回答由三位研究人员分别进行了主题编码,然后进行了分类。结果IA患者报告的障碍和促进因素个体间差异较大。可以基于适应性TDF在以下领域捕获已识别的障碍和促进者:(i)知识,(ii)情感,(iii)注意,记忆和决策过程,(iv)社会影响,(v)关于能力(vi)对后果的信念,(vii)动机和目标,(viii)目标冲突,(ix)环境背景和资源以及(x)技能。结论IA患者在使用DMARD方面存在多种障碍和促进因素。所有这些障碍和促进者都可以归类为TDF的适用领域。需要制定基于能力,机会和动机的干预措施,以解决个体促成者和障碍,以制定适合个体患者需求的药物依从性策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号